Welcome to our dedicated page for Commvault Sys SEC filings (Ticker: CVLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Commvault’s cyber-resilience business produces filings packed with technical terms like deduplication, ransomware honeypots, and subscription ARR. If you’ve ever googled “Commvault SEC filings explained simply,� you know how hard it is to isolate the metrics that drive valuation—cloud subscription growth, deferred revenue, or which patents defend the Metallic platform. Stock Titan’s AI-powered summaries surface those numbers and risks in seconds, ending the page-by-page hunt.
Whether you’re checking a Commvault quarterly earnings report 10-Q filing for segment margins or monitoring Commvault insider trading Form 4 transactions, our real-time feed captures every form the moment it hits EDGAR. Explore:
- Commvault annual report 10-K simplified � compare license versus subscription revenue trends
- Commvault 8-K material events explained � see how partnerships or ransomware incidents move guidance
- Commvault Form 4 insider transactions real-time � track executive buys and sells before earnings
- Commvault proxy statement executive compensation � review pay tied to cloud ARR milestones
- Commvault earnings report filing analysis � AI extracts KPIs, cash flow, and backlog changes
- Commvault executive stock transactions Form 4 � receive instant email alerts
Still understanding Commvault SEC documents with AI? Stock Titan turns disclosure overload into useful insight: machine-generated abstracts, red-flag detection, and quarter-over-quarter comparisons. With expert analysis, real-time updates, and comprehensive filing coverage, investors move from raw data to clear decisions in minutes—no forensic accounting degree required.
Form 144 notice for Commvault Systems, Inc. (CVLT): This filing notifies the proposed sale of 6,614 shares of Common stock through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $1,190,652.28 and approximately 44,513,830 shares outstanding. The securities to be sold include Restricted Stock (10,280 shares) and Performance Stock (6,523 shares) acquired from the issuer on 08/15/2025, with payment dated 08/15/2025. The filer has reported multiple recent open-market Common stock sales during May 2025 totaling 94,664 shares generating gross proceeds shown per transaction. The notice includes the filer’s representation that they have no undisclosed material adverse information.
Commodult Systems, Inc. (CVLT) filed a Form 144 reporting a proposed sale of common stock. The notice shows 11,035 shares to be sold through Morgan Stanley Smith Barney, LLC with an aggregate market value of $1,986,520.70, and cites approximately 44,513,830 shares outstanding. The proposed sale date is 08/18/2025. The filing discloses that the securities were acquired on 08/15/2025 as restricted stock (17,446 shares) and performance stock (8,614 shares). The filer reports no securities sold in the past three months and includes the standard signature representation about material nonpublic information.
Form 144 notice for Commvault Systems, Inc. (CVLT) reporting proposed sale of 2,594 common shares through Morgan Stanley Smith Barney on 08/18/2025 with an aggregate market value of $466,971.88. The filing lists acquisition entries showing the filer acquired 3,505 restricted shares and 2,243 performance shares on 08/15/2025 from the issuer, with payment noted as not applicable. The filing also discloses multiple open-market sales by Gary Merrill during May 2025 totaling 36,827 shares and gross proceeds of $6,539,565.26. The filer certifies no undisclosed material adverse information.
Sanders A. Shane, a director of Commvault Systems, Inc. (CVLT), reported a grant of 1,189 restricted stock units (RSUs) on 08/07/2025. The RSUs are recorded as common stock and will vest 100% on the later of the one-year anniversary of the grant or the date of the 2026 Annual Meeting of Shareholders; the filing shows his beneficial ownership at 8,023 shares prior to the sale.
On 08/11/2025 Mr. Shane sold 612 shares at $182.92. The sale was effected pursuant to an existing Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. After the reported transactions his direct beneficial ownership is shown as 7,411 shares. The Form 4 was executed on 08/11/2025 by an attorney-in-fact, Danielle Abrahamsen.
Commvault director Vivie Lee received 1,189 restricted stock units that vest 100% on the later of the one-year anniversary of grant or the 2026 Annual Meeting, increasing her reported beneficial ownership to 14,739 shares. The award was reported as a grant with a $0 cash price, reflecting typical equity compensation in the form of restricted stock units.
Subsequently, Lee sold 765 shares at $182.92 per share pursuant to a pre-existing Rule 10b5-1 trading plan adopted February 3, 2025, reducing her beneficial ownership to 13,974 shares. The transactions are routine director compensation and plan-based selling; no derivative transactions or exercisable options are reported.
Allison Pickens, a director of Commvault Systems (CVLT), was granted 1,189 restricted stock units (RSUs) on 08/07/2025. The award is recorded as an acquisition at no cash price and increases her beneficial ownership to 5,856 common shares. The RSUs are subject to a single vesting event: they vest 100% on the later of the one-year anniversary of the grant or the date of the 2026 Annual Meeting of Shareholders.
The grant aligns a board member’s compensation with shareholder value by delivering equity rather than cash and formally appears on a Form 4 insider report as an acquisition of non-derivative securities. The filing was submitted by an attorney-in-fact on behalf of the reporting person and includes the required explanatory note on vesting.
The Form 4 shows director Charles E. Moran received a grant of 1,189 restricted stock units (RSUs) in Commvault Systems, Inc. (ticker CVLT) with a transaction date of 08/07/2025. The RSUs were granted at a price of $0 (typical for restricted awards) and are reported as acquired shares.
The filing reports 13,686 shares of common stock beneficially owned by Mr. Moran following the reported transaction, held in a direct ownership form. The award is described as vesting 100% on the later of the one-year anniversary of the grant or the date of the 2026 Annual Meeting of Shareholders.
Adamo Nicola, a director of Commvault Systems (CVLT), was granted 1,189 restricted stock units (RSUs) of common stock on 08/07/2025, issued with no purchase price.
The award increases his direct beneficial ownership to 17,367 shares. The RSUs vest 100% on the later of the one-year anniversary of the grant or the date of the 2026 Annual Meeting of Shareholders, making the grant time‑based and tied to the next shareholder meeting.
Martha Helena Bejar, a director of Commvault Systems Inc. (CVLT), acquired 1,189 restricted stock units (RSUs) on 08/07/2025 as reported on Form 4. The grant is recorded as an acquisition at a $0 price and increases her direct beneficial ownership to 7,036 shares. The RSUs vest 100% on the later of the one‑year anniversary of the grant or the date of the 2026 Annual Meeting of Shareholders.
The filing shows a straightforward equity award to a board member with no derivative instruments reported and documents the post‑grant share count; it does not disclose additional cash compensation, option grants, or other transactions.
Keith Geeslin, identified as a director of Commvault Systems Inc. (CVLT), reported an equity award on a Form 4 with a transaction date of 08/07/2025. Table I of the filing shows Common Stock entries including the figures 1,189 and $0, and a reported beneficial ownership figure of 34,180 following the reported transaction(s). The filing's explanation states these shares are being granted as restricted stock units, 100% of which shall vest on the later of the one-year anniversary of the grant or the date of the 2026 Annual Meeting of Shareholders. The form is signed on behalf of the reporting person by Danielle Abrahamsen, Attorney-in-Fact, dated 08/11/2025. The filing otherwise contains routine disclosure language for a director equity grant.